|
1
|
Robinson D, Van Allen EM, Wu YM, Schultz
N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC,
Attard G, et al: Integrative clinical genomics of advanced prostate
cancer. Cell. 161:1215–1228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song W and Jeon HG: Incidence of kidney,
bladder, and prostate cancers in Korea: An update. Korean J Urol.
56:422–428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Nunzio C, Albisinni S, Freedland SJ,
Miano L, Cindolo L, Finazzi Agrò E, Autorino R, De Sio M, Schips L
and Tubaro A: Abdominal obesity as risk factor for prostate cancer
diagnosis and high grade disease: A prospective multicenter Italian
cohort study. Urol Oncol. 31:997–1002. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krupski TL, Stukenborg GJ, Moon K and
Theodorescu D: The relationship of palliative transurethral
resection of the prostate with disease progression in patients with
prostate cancer. BJU Int. 106:1477–1483. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu L, Tian Z, Zhang Z and Fei B:
Computer-aided detection of prostate cancer with MRI: Technology
and applications. Acad Radiol. 23:1024–1046. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koval M: Claudin heterogeneity and control
of lung tight junctions. Annu Rev Physiol. 75:551–567. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Neesse A, Hahnenkamp A, Griesmann H,
Buchholz M, Hahn SA, Maghnouj A, Fendrich V, Ring J, Sipos B,
Tuveson DA, et al: Claudin-4-targeted optical imaging detects
pancreatic cancer and its precursor lesions. Gut. 62:1034–1043.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mosley M, Knight J, Neesse A, Michl P,
Iezzi M, Kersemans V and Cornelissen B: Claudin-4 SPECT imaging
allows detection of aplastic lesions in a mouse model of breast
cancer. J Nucl Med. 56:745–751. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bezdekova M, Brychtova S, Sedlakova E,
Langova K, Brychta T and Belej K: Analysis of Snail-1, E-cadherin
and claudin-1 expression in colorectal adenomas and carcinomas. Int
J Mol Sci. 13:1632–1643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li JY, Xie F, Xu XP, Ma JJ, Zhou DC, Liao
Y, Tang J, Xie Q, Bai L and Nan QZ: Claudin-3 expression in
colorectal carcinoma and its significance. Nan Fang Yi Ke Da Xue
Xue Bao. 37:63–67. 2017.(In Chinese). PubMed/NCBI
|
|
11
|
Jones N, Bonnet F, Sfar S, Lafitte M,
Lafon D, Sierankowski G, Brouste V, Banneau G, Tunon de Lara C,
Debled M, et al: Comprehensive analysis of PTEN status in breast
carcinomas. Int J Cancer. 133:323–334. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Feng J, Fu H, Liu C, Yu Z, Sun Y,
She X, Li P, Zhao C, Liu Y, et al: Coagulation factor X regulated
by CASC2c recruited macrophages and induced M2 polarization in
glioblastoma multiforme. Front Immunol. 9:15572018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wise HM, Hermida MA and Leslie NR:
Prostate cancer, PI3K, PTEN and prognosis. Clin Sci (Lond).
131:197–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang LL, Liu J, Lei S, Zhang J, Zhou W
and Yu HG: PTEN inhibits the invasion and metastasis of gastric
cancer via downregulation of FAK expression. Cell Signal.
26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang J, Yuan SX, Wang DX, Wu QX, Wang X,
Pi CJ, Zou X, Chen L, Ying LJ, Wu K, et al: The role of COX-2 in
mediating the effect of PTEN on BMP9 induced osteogenic
differentiation in mouse embryonic fibroblasts. Biomaterials.
35:9649–9659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu M, Mu Y, Qi Y, Qin S, Qiu Y, Cui R and
Zhong M: Odontogenic ameloblast-associated protein (ODAM) inhibits
human colorectal cancer growth by promoting PTEN elevation and
inactivating PI3K/AKT signaling. Biomed Pharmacother. 84:601–607.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stamatiou K, Alevizos A, Karanasiou V,
Mariolis A, Mihas C, Papathanasiou M, Bovis K and Sofras F: Impact
of additional sampling in the TRUS-guided biopsy for the diagnosis
of prostate cancer. Urol Int. 78:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Albert RH and Clark MM: Cancer screening
in the older patient. Am Fam Physician. 78:1369–1374.
2008.PubMed/NCBI
|
|
19
|
Coakley FV, Oto A, Alexander LF, Allen BC,
Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni
VA, et al Expert Panel on Urologic Imaging, : ACR Appropriateness
criteria® prostate cancer-pretreatment detection,
surveillance and staging. J Am Coll Radiol. 14:S245–S257. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bailey DE Jr and Wallace M: Critical
review: Is watchful waiting a viable management option for older
men with prostate cancer? Am J Men Health. 1:18–28. 2007.
View Article : Google Scholar
|
|
21
|
de Oliveira Barros EG, Palumbo A Jr, Mello
PL, de Mattos RM, da Silva JH, Pontes B, Viana NB, do Amaral RF,
Lima FR, da Costa NM, et al: The reciprocal interactions between
astrocytes and prostate cancer cells represent an early event
associated with brain metastasis. Clin Exp Metastasis. 31:461–474.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sinibaldi VJ: Docetaxel treatment in the
elderly patient with hormone refractory prostate cancer. Clin
Interv Aging. 2:555–560. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yokoyama M, Narita T, Sakurai H,
Katsumata-Kato O, Sugiya H and Fujita-Yoshigaki J: Maintenance of
claudin-3 expression and the barrier functions of intercellular
junctions in parotid acinar cells via the inhibition of Src
signaling. Arch Oral Biol. 81:141–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang XD, Zhao SF, Zhang Q, Li W, Wang YX,
Hong XW and Hu QG: PTEN gene polymorphisms and susceptibility to
oral squamous cell carcinoma in a Chinese Han population. Tumour
Biol. 37:577–582. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Guo JX and Shao ZQ: miR-21 targets
and inhibits tumor suppressor gene PTEN to promote prostate cancer
cell proliferation and invasion: An experimental study. Asian Pac J
Trop Med. 10:87–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song
B, Cheng L, Masterson TA, Liu X, Ratliff TL, et al: Cholesteryl
ester accumulation induced by PTEN loss and PI3K/AKT activation
underlies human prostate cancer aggressiveness. Cell Metab.
19:393–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chinni SR, Li Y, Upadhyay S, Koppolu PK
and Sarkar FH: Indole-3-carbinol (I3C) induced cell growth
inhibition, G1 cell cycle arrest and apoptosis in prostate cancer
cells. Oncogene. 20:2927–2936. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Phattarataratip E and Sappayatosok K:
Expression of claudin-5, claudin-7 and occludin in oral squamous
cell carcinoma and their clinico-pathological significance. J Clin
Exp Dent. 8:e299–e306. 2016.PubMed/NCBI
|
|
29
|
Koperek O, Kornauth C, Capper D, Berghoff
AS, Asari R, Niederle B, von Deimling A, Birner P and Preusser M:
Immunohistochemical detection of the BRAF V600E-mutated protein in
papillary thyroid carcinoma. Am J Surg Pathol. 36:844–850. 2012.
View Article : Google Scholar : PubMed/NCBI
|
